Examples of 'edoxaban' in a sentence
Meaning of "edoxaban"
Edoxaban is a type of anticoagulant or blood thinner used to prevent blood clots in medical treatment
Show more definitions
- An anticoagulant drug.
How to use "edoxaban" in a sentence
Basic
Advanced
edoxaban
Unchanged edoxaban is the predominant form in plasma.
Lixiana contains the active substance edoxaban.
Overdose with edoxaban may lead to haemorrhage.
Roteas contains the active substance edoxaban.
Edoxaban was excreted in the breast milk of lactating rats.
The active substance is edoxaban as tosilate.
Edoxaban and initial parenteral anticoagulant should not be administered simultaneously.
Chronic use of NSAIDs with edoxaban is not recommended.
Women of childbearing potential should avoid becoming pregnant during treatment with edoxaban.
Effect of edoxaban on other medicines.
A specific antidote antagonising the pharmacodynamic effect of edoxaban is not available.
Safety and efficacy of edoxaban have not been established in pregnant women.
Protamine sulfate and vitamin K are not expected to affect the anticoagulant activity of edoxaban.
No specific studies with edoxaban in humans have been conducted to evaluate effects on fertility.
Naproxen had no effect on the Cmax and AUC of edoxaban.
See also
Data from animals indicate that edoxaban is secreted into breast milk.
Edoxaban had no effect on the Cmax and AUC of quinidine.
Due to the high plasma protein binding edoxaban is not expected to be dialysable.
Edoxaban is a factor Xa antagonist.
Lixiana contains the active substance edoxaban and belongs to a group of medicines called anticoagulants.
Edoxaban is currently marketed in Japan and the United States.
Roteas contains the active substance edoxaban and belongs to a group of medicines called anticoagulants.
Edoxaban vs Warfarin.
Co-administration of protonpump inhibitors had no relevant impact on edoxaban exposure.
The anticoagulant effect of edoxaban can not be reliably monitored with standard laboratory testing.
Co-administration of proton - pump inhibitors had no relevant impact on edoxaban exposure.
Therapy with edoxaban in NVAF patients should be continued long term.
Effects of coagulation markers when switching from rivaroxaban, dabigatran, or apixaban to edoxaban.
Therefore, use of edoxaban is not recommended in these patients.
Reproduction is authorised provided the source is acknowledged . edoxaban from the body.
Safety and efficacy of edoxaban have not been established in breast-feeding women.
There is no experience with antifibrinolytic agents ( tranexamic acid, aminocaproic acid ) in individuals receiving edoxaban.
However, there is no recommendation that edoxaban be administered concomitantly with food.
Dose of edoxaban needs to be reduced when used concomitantly, please consult edoxaban SmPC.
Co-administration of Vosevi with edoxaban is not recommended.
Edoxaban increases the risk of bleeding and can cause serious, potentially fatal bleeding.
Common other adverse reactions for edoxaban were anaemia, rash and abnormal liver function tests.
Edoxaban is a substrate for the efflux transporter P-gp.
There is a linear correlation between edoxaban plasma concentration and anti-FXa activity regardless of renal function.
Edoxaban inhibits free factor Xa, and prothrombinase activity.
The structural formula of Edoxaban is shown below,.
Rivaroxaban and edoxaban stood out because of their convenient administration, with just one daily intake.
Co-administration of apixaban, rivaroxaban or edoxaban is not recommended with Stribild.
Edoxaban is absorbed with peak plasma concentrations within 1 - 2 hours.
Co-administration of apixaban, rivaroxaban or edoxaban is not recommended with Genvoya.
Edoxaban displays approximately dose-proportional pharmacokinetics for doses of 15 mg to 60 mg in healthy subjects.
Co-administration of apixaban, rivaroxaban or edoxaban is not recommended with Tybost.
Edoxaban has not been studied in patients with severe hepatic impairment see section 4.2.
Prevention of stroke and systemic embolism The recommended dose is 60 mg edoxaban once daily.
NSAIDs, Co-administration of naproxen and edoxaban increased bleeding time relative to either medicine alone.
